73 related articles for article (PubMed ID: 21042766)
1. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
Liao X; Che X; Zhao W; Zhang D; Bi T; Wang G
Oncol Rep; 2010 Dec; 24(6):1669-76. PubMed ID: 21042766
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3.
Yu RX; Yu RT; Liu Z
Hum Cell; 2018 Jan; 31(1):50-63. PubMed ID: 29110251
[TBL] [Abstract][Full Text] [Related]
3. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Vascular Endothelial Growth Factor Signaling by Nicotine in a Manner Dependent on Acetylcholine-and/or β-Adrenergic-Receptors in Human Lung Cancer Cells.
Al Khashali H; Darweesh B; Ray R; Haddad B; Wozniak C; Ranzenberger R; Goel S; Khalil J; Guthrie J; Heyl D; Evans HG
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067204
[TBL] [Abstract][Full Text] [Related]
5. "Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.
Tennakoon G; Auer R
Brain Behav Immun; 2023 Jul; 111():247-248. PubMed ID: 37127226
[TBL] [Abstract][Full Text] [Related]
6. The antagonist of β-adrenergic receptor propranolol inhibits T cell lymphoma growth and enhances antitumor efficacy of cisplatin in vivo: A role of modulated apoptosis, glucose metabolism, pH regulation, and antitumor immune response.
Tiwari RK; Rawat SG; Kumar A
Int Immunopharmacol; 2023 Nov; 124(Pt A):110825. PubMed ID: 37619412
[TBL] [Abstract][Full Text] [Related]
7. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
Powe DG; Voss MJ; Zänker KS; Habashy HO; Green AR; Ellis IO; Entschladen F
Oncotarget; 2010 Nov; 1(7):628-638. PubMed ID: 21317458
[TBL] [Abstract][Full Text] [Related]
8. Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.
Wang F; Liu H; Wang F; Xu R; Wang P; Tang F; Zhang X; Zhu Z; Lv H; Han T
Mol Med Rep; 2018 Apr; 17(4):5213-5221. PubMed ID: 29393410
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways: beta-adrenergic signaling in cancer.
Cole SW; Sood AK
Clin Cancer Res; 2012 Mar; 18(5):1201-6. PubMed ID: 22186256
[TBL] [Abstract][Full Text] [Related]
10. Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells.
Bernabé DG; Tamae AC; Biasoli ÉR; Oliveira SH
Brain Behav Immun; 2011 Mar; 25(3):574-83. PubMed ID: 21187140
[TBL] [Abstract][Full Text] [Related]
11. Trial watch: beta-blockers in cancer therapy.
Carnet Le Provost K; Kepp O; Kroemer G; Bezu L
Oncoimmunology; 2023; 12(1):2284486. PubMed ID: 38126031
[TBL] [Abstract][Full Text] [Related]
12. Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis.
He X; Zhao Z; Jiang X; Sun Y
Front Pharmacol; 2023; 14():1216059. PubMed ID: 37538177
[No Abstract] [Full Text] [Related]
13. Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.
Puzderova B; Belvoncikova P; Grossmannova K; Csaderova L; Labudova M; Fecikova S; Pastorek J; Barathova M
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446271
[TBL] [Abstract][Full Text] [Related]
14. Harnessing interventions during the immediate perioperative period to improve the long-term survival of patients following radical gastrectomy.
Liu LB; Li J; Lai JX; Shi S
World J Gastrointest Surg; 2023 Apr; 15(4):520-533. PubMed ID: 37206066
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
Wu YL; van Hyfte G; Özbek U; Reincke M; Gampa A; Mohamed YI; Nishida N; Wietharn B; Amara S; Lee PC; Scheiner B; Balcar L; Pinter M; Vogel A; Weinmann A; Saeed A; Pillai A; Rimassa L; Naqash AR; Muzaffar M; Huang YH; Kaseb AO; Kudo M; Pinato DJ; Ang C
Front Oncol; 2023; 13():1128569. PubMed ID: 36865801
[TBL] [Abstract][Full Text] [Related]
16. Repurposed Drugs in Gastric Cancer.
Araújo D; Ribeiro E; Amorim I; Vale N
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615513
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Drugs in Small Animal Oncology.
Giuliano A; Horta RS; Vieira RAM; Hume KR; Dobson J
Animals (Basel); 2022 Dec; 13(1):. PubMed ID: 36611747
[TBL] [Abstract][Full Text] [Related]
18. Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1.
Hu Q; Hu J; Chen C; Wang Y; Zhang Y; Wan J; Jing O; Yi H; Wang S; Huang W; Liu J; Zhang W; McLeod HL; Xu R; He Y
Transl Androl Urol; 2022 Aug; 11(8):1083-1095. PubMed ID: 36092839
[TBL] [Abstract][Full Text] [Related]
19. Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.
Albiñana V; Gallardo-Vara E; Casado-Vela J; Recio-Poveda L; Botella LM; Cuesta AM
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956154
[TBL] [Abstract][Full Text] [Related]
20. Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma.
Altshuler E; Aryan M; Kallumkal G; Gao H; Wilson J; Ouni A; De Leo E; Hanayneh W; Pan K
Hepat Oncol; 2022 Apr; 9(2):HEP43. PubMed ID: 35665305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
